Home › Erdheim-Chester Disease › New York
Erdheim-Chester Disease clinical trials in New York
5 studies for Erdheim-Chester Disease are looking for participants at sites in New York.
Cities in New York
Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT03329274Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
All ages · All sexes · Updated Oct 26, 2026 · NCT04079179Supportive Care Needs of Caregivers of People With Erdheim-Chester Disease and Other Histiocytic Diseases
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 2, 2026 · NCT03990428ECD-Score: a Study on Erdheim-Chester Disease
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
Ages 7 and older · All sexes · Updated Mar 6, 2026 · NCT07454343International Rare Histiocytic Disorders Registry (IRHDR)
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational study
All ages · All sexes · Updated Jun 24, 2025 · NCT02285582From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.